38 related articles for article (PubMed ID: 2511719)
21. Chemotherapy of Hodgkin's disease.
Young RC; DeVita VT
Clin Haematol; 1979 Oct; 8(3):625-44. PubMed ID: 91466
[TBL] [Abstract][Full Text] [Related]
22. Thymic hyperplasia following successful treatment for nodular-sclerosing Hodgkin's disease.
Scheinpflug K; Schmitt J; Jentsch-Ullrich K; Roessner A; Franke A
Leuk Lymphoma; 2003 Sep; 44(9):1615-7. PubMed ID: 14565667
[TBL] [Abstract][Full Text] [Related]
23. Hodgkin's disease in adults. Part I.
Urba WJ; Longo DL
Invest Radiol; 1993 Aug; 28(8):737-52. PubMed ID: 8376007
[No Abstract] [Full Text] [Related]
24. Prognostic factors in decision-making in the clinical management of Hodgkin's disease.
Hagemeister FB
Hematol Oncol; 1988; 6(3):257-69. PubMed ID: 3042583
[TBL] [Abstract][Full Text] [Related]
25. High dose therapy for Hodgkin's disease.
Bhidayasira R; Linch D
Blood Rev; 1999 Mar; 13(1):45-50. PubMed ID: 10225608
[TBL] [Abstract][Full Text] [Related]
26. Complete remission of paraneoplastic vanishing bile duct syndrome after the successful treatment of Hodgkin's lymphoma: a case report and review of the literature.
Rota Scalabrini D; Caravelli D; Carnevale Schianca F; D'Ambrosio L; Tolomeo F; Boccone P; Manca A; De Rosa G; Nuzzo A; Aglietta M; Grignani G
BMC Res Notes; 2014 Aug; 7():529. PubMed ID: 25125318
[TBL] [Abstract][Full Text] [Related]
27. Hodgkin's disease. Treatment of the young child.
Donaldson SS; Link MP
Pediatr Clin North Am; 1991 Apr; 38(2):457-73. PubMed ID: 1747155
[TBL] [Abstract][Full Text] [Related]
28. Erythema nodosum and Hodgkin's disease.
Taillan B; Ferrari E; Fuzibet JG; Vinti H; Pesce A; Dujardin P
Clin Rheumatol; 1990 Sep; 9(3):397-8. PubMed ID: 2261740
[TBL] [Abstract][Full Text] [Related]
29. Meningeal localization in a patient with Hodgkin's disease. Description of a case and review of the literature.
Anselmo AP; Proia A; Cartoni C; Baroni CD; Maurizi Enrici R; Delfini R; Avvisati G
Ann Oncol; 1996 Dec; 7(10):1071-5. PubMed ID: 9037367
[TBL] [Abstract][Full Text] [Related]
30. Infections in patients with Hodgkin's disease: a clinical study of 300 consecutive adult patients.
Notter DT; Grossman PL; Rosenberg SA; Remington JS
Rev Infect Dis; 1980; 2(5):761-800. PubMed ID: 6763305
[TBL] [Abstract][Full Text] [Related]
31. Modern treatment of malignant lymphomas: a multidisciplinary approach? The Kaplan Memorial Lecture.
Bonadonna G
Ann Oncol; 1994; 5 Suppl 2():5-16. PubMed ID: 8204520
[TBL] [Abstract][Full Text] [Related]
32. Paediatric Hodgkin's disease.
Pötter R
Eur J Cancer; 1999 Oct; 35(10):1466-74; discussion 1474-6. PubMed ID: 10673979
[No Abstract] [Full Text] [Related]
33. Late complications after Hodgkin's disease.
Henry-Amar M; Joly F
Ann Oncol; 1996; 7 Suppl 4():115-26. PubMed ID: 8836422
[TBL] [Abstract][Full Text] [Related]
34. Free-from-failure survival in Hodgkin's disease. Long-term analysis of 148 cases treated with a MOPP-modified protocol.
Silingardi V; Federico M; Frassoldati A; Barbieri F; Palomba G; Mauri C
Acta Haematol; 1989; 82(4):179-86. PubMed ID: 2511719
[TBL] [Abstract][Full Text] [Related]
35. [Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
Arranz R; Gil-Fernández JJ; Muñoz E; Acevedo A; Sobrino MP; Fernández-Rañada JM
Sangre (Barc); 1998 Jun; 43(3):179-84. PubMed ID: 9741222
[TBL] [Abstract][Full Text] [Related]
36. [The management of Hodgkin's disease with chemotherapy or combined modality treatment].
Tsushita K; Utsumi M; Shimoyama M
Gan To Kagaku Ryoho; 1998 Dec; 25(14):2202-9. PubMed ID: 9881076
[TBL] [Abstract][Full Text] [Related]
37. Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease.
Andrieu JM; Ifrah N; Payen C; Fermanian J; Coscas Y; Flandrin G
J Clin Oncol; 1990 Jul; 8(7):1148-54. PubMed ID: 2193118
[TBL] [Abstract][Full Text] [Related]
38. Semantics and the chemotherapy of Hodgkin's disease--resistance is not relapse: alternative chemotherapy lacks effectiveness for disease not totally responsive to initial MOPP treatment.
Coleman M; Friedlander RJ
Cancer Invest; 1988; 6(2):237-9. PubMed ID: 3288299
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
